Stanford, CA, United States of America

Mehrdad Shamloo

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Palo Alto, CA (US) (2015)
  • Stanford, CA (US) (2017 - 2021)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Mehrdad Shamloo**

Introduction

Mehrdad Shamloo is a distinguished inventor based in Stanford, California. With a strong background in pharmaceutical sciences, he has made significant contributions to the field through his innovative inventions. He holds three patents that focus on adrenergic receptor modulation, aimed at improving treatment options for various medical conditions.

Latest Patents

Mehrdad Shamloo's latest patents include groundbreaking work on adrenergic receptor modulating compounds. These compounds provide methods of treating diseases or conditions associated with adrenergic receptors. Specifically, his patents discuss methods for modulating inflammatory pathways in cells, such as the production of TNF-alpha, using β1-selective adrenergic receptor modulating compounds. This approach allows for the selective activation of the cAMP pathway over the beta-arrestin pathway, enhancing therapeutic outcomes.

Another significant patent focuses on improving cognition and social behavior in individuals experiencing deficits due to neurodegenerative disorders. This invention involves a β-ADR agonist prodrug compound that is hydrolyzable in vivo to release a β1-ADR agonist compound, designed to enhance lipophilicity and CNS bioavailability compared to the original agonist compound.

Career Highlights

Mehrdad Shamloo is associated with Leland Stanford Junior University, a prestigious research institution that supports his innovative work. His ongoing research contributes to understanding complex biological processes and developing novel therapeutic strategies.

Collaborations

Throughout his career, Shamloo has collaborated with notable colleagues, including Bitna Yi and Alam Jahangir. These collaborations underscore the importance of teamwork in advancing scientific research and the development of new medical therapies.

Conclusion

In summary, Mehrdad Shamloo is a pioneering inventor whose work on adrenergic receptor modulating compounds holds promise for addressing significant medical challenges. His patents not only reflect his commitment to scientific innovation but also highlight the collaborative spirit inherent in research institutions like Leland Stanford Junior University. As the field of pharmaceuticals continues to evolve, contributions from inventors like Shamloo remain crucial for developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…